AI Discovery
Hypotheses, candidates, simulations, and AI-assisted drafts with their sources and decisions.
Draft with AI, attach evidence, route reviews, and sign, in workspaces built for discovery, clinical research, manufacturing, and QC.
Cloud beta: the controlled documents workspace is available now, free at simsai.co. Lifecycle workspaces deploy on-premise.
Unlimited seats. You pay only for AI use. See SIMS pricing
Discovery flows into studies, studies into batches, batches into QC. Each workspace speaks the language of the team that owns it.
Hypotheses, candidates, simulations, and AI-assisted drafts with their sources and decisions.
Studies, protocols, specimens, and sponsor collaboration with scoped access and audit trails.
Batch records, production documents, and release context with full version history.
LIMS-style testing, COAs, specifications, and stability programs connected to the batches and studies they certify.
The AI Discovery workspace is where exploration happens: ask questions, compare candidates, and generate drafts that any reviewer can trace back to their sources.
Prompts run against your project's sources and history, not a blank chat.
Hypotheses, comparisons, and simulation context stay attached to the candidates they produced.
Generated sections move into review with their evidence, ready for human judgment.
Drafts, reviews, signatures, downloads, and exports land in a single governed record, whether the actor is your scientist, your sponsor, or an AI agent. Each sponsor works inside a view scoped to their studies, and every action they take still lands in your log.
Documents carry their full history: every version, every approval, every export.
Access scoped to each document and record, with a log of who saw, signed, edited, or downloaded what, and when.
AI-assisted sections get human eyes before they get signatures. Reviewers can challenge, correct, and approve.
Give each client, sponsor, or external lab exactly the view they need — nothing more.
Generic AI tools forget where claims came from. SIMS never does.
SIMS was born in a Health Canada–licensed lab (DEL · CDS) that lives cGMP every day — not in a generic SaaS playbook.
Draft, compare, and summarize where the evidence lives, so review starts instead of starting over.
Sources, edits, approvals, and exports stay inspectable. When the question is "why did we conclude this?", the answer is one click away.
Start as a three-person lab in the cloud beta; scale to subsidiaries and external partners on the same platform.
The same path every time: draft with AI, attach evidence, review, sign, export.
Start from a template or a prompt. The draft lands in the project, not in a chat window.
Link sources, lab results, and prior decisions to the claims they support.
Reviewers comment, request changes, and sign off, with every action logged.
Send the signed record out with its full history attached, ready for any audit.
Sign up free at simsai.co and put a real document through draft, review, and signoff. When you're ready for more, Finepoint deploys lifecycle workspaces on-premise.